Skip to main content Skip to footer
PipelineReview. Business Intellegence Center
  • Home
  • News Channels
    • Antibodies
    • Proteins and Peptides
    • Vaccines
    • DNA RNA and Cells
    • Small Molecules
    • More News
    • All News
  • Reports
  • Press Room
  • Contact Us
  • About Us

Therapeutic Proteins & Peptides

Mar 2024

2023 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

130,00€
Mar 2024

Biologics Sales Database for Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and RNA

250,00€
Jan 2024

Nectin-4-Targeted Immunotherapy Pipeline Review

200,00€
Sep 2023

PSMA-Targeted Therapy Pipeline Review

400,00€
Aug 2023

CD40 Agonists & CD40/L Antagonists Pipeline Review

300,00€
Aug 2023

Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

300,00€
Oct 2021

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

2.250,00€

Report categories

    Antibody & Protein Sales
    Antibody Technologies
    Biosimilar Antibodies & Proteins
    CAR T-Cells
    Drug the Undruggable Technologies
    Immuno-Oncology
    mRNA Vaccines & Therapeutics
    NK Cells & CAR Macrophages
    Pipeline Database
    RNA-Targeted Therapeutics
    Target Pipelines
    TCR T-Cells and Antibodies
    Therapeutic Antibodies
    Therapeutic Proteins & Peptides
PipelineReview.com is powered by La Merie Business IntelligenceFor immediate assistance, please call us during business hours:
Mon-Fri 10:00am - 05:00pm; GMT+01
La Merie Publishing - Ulrich Martin
Badstrasse 11 | 97990 Weikersheim | Germnay | T +49-176 8016 8139 | Email info@lamerie.com

All contents © by La Merie Publishing

  • Terms and Conditions
    Privacy Policy
    Submit your Press Release
    Imprint
Programa Kit Digital cofinanciado por los fondos Next Generation (EU)
del mecanismo de recuperación y resilencia
NextGeneration-EUPlan de recuperación, transformación y resilencia